Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

JAZZ holding history

Jazz Pharmaceuticals plc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JAZZ overviewAll 13F holders of JAZZFull Q2 2026 holdings

Shares (Q2 2026)
7,784
Value
$1.88M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of JAZZ by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,784$1.88M<0.1%+151+2.0%AddedHolders
Q1 20267,633$1.44M<0.1%+1,252+19.6%AddedHolders
Q4 20256,381$1.08M<0.1%−1,270−16.6%ReducedHolders
Q3 20257,651$1.01M<0.1%−732−8.7%ReducedHolders
Q2 20258,383$889.6K<0.1%−211−2.5%ReducedHolders
Q1 20258,594$1.07M<0.1%+648+8.2%AddedHolders
Q4 20247,946$978.5K<0.1%+1,195+17.7%AddedHolders
Q3 20246,751$752.1K<0.1%−23−0.3%ReducedHolders
Q2 20246,774$723.0K<0.1%−6,418−48.7%ReducedHolders
Q1 202413,192$1.59M<0.1%+2,590+24.4%AddedHolders
Q4 202310,602$1.30M<0.1%−346−3.2%ReducedHolders
Q3 202310,948$1.42M<0.1%−203−1.8%ReducedHolders
Q2 202311,151$1.38M<0.1%+2,782+33.2%AddedHolders
Q1 20238,369$1.22M<0.1%+36+0.4%AddedHolders
Q4 20228,333$1.33M<0.1%+957+13.0%AddedHolders
Q3 20227,376$983.0K<0.1%−93−1.2%ReducedHolders
Q2 20227,469$1.17M<0.1%+598+8.7%AddedHolders
Q1 20226,871$1.07M<0.1%−52−0.8%ReducedHolders
Q4 20216,923$882.0K<0.1%−17−0.2%ReducedHolders
Q3 20216,940$904.0K<0.1%−193−2.7%ReducedHolders
Q2 20217,133$1.27M<0.1%+1,171+19.6%AddedHolders
Q1 20215,962$980.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.